• SPX
  • $5,948.71
  • 0.53 %
  • $31.60
  • DJI
  • $43,870.35
  • 1.06 %
  • $461.88
  • N225
  • $38,366.18
  • 0.89 %
  • $340.08
  • FTSE
  • $8,149.27
  • 0.79 %
  • $64.20
  • IXIC
  • $18,972.42
  • 0.03 %
  • $6.28
Penumbra, Inc. (PEN) Stock Price, News & Analysis

Penumbra, Inc. (PEN) Stock Price, News & Analysis

Currency in USD Disclaimer

$240.54

$1.34

(0.56%)

Day's range
$235.93
Day's range
$240.97
50-day range
$184.8
Day's range
$243.39
  • Country: US
  • ISIN: US70975L1070
52 wk range
$148
Day's range
$277.34


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 16.11
  • Piotroski Score 6.00
  • Grade Overweight
  • Symbol (PEN)
  • Company Penumbra, Inc.
  • Price $240.54
  • Changes Percentage (0.56%)
  • Change $1.34
  • Day Low $235.93
  • Day High $240.97
  • Year High $277.34

Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand, as well as immersive computer-based technologies and immersive therapeutics to promote health, motor function, and cognition under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 02/20/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $235.00
  • High Stock Price Target $285.00
  • Low Stock Price Target $150.00
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $2.38
  • Trailing P/E Ratio 79.39
  • Forward P/E Ratio 79.39
  • P/E Growth 79.39
  • Net Income $90.95 M

Income Statement

Quarterly

Annual

Latest News of PEN

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Penumbra, Inc. Frequently Asked Questions

  • What were the earnings of PEN in the last quarter?

    In the last quarter Penumbra, Inc. earnings were on Wednesday, October, 30th. The Penumbra, Inc. maker reported $0.85 EPS for the quarter, beating analysts' consensus estimates of $0.69 by $0.16.

  • What is the Penumbra, Inc. stock price today?

    Today's price of Penumbra, Inc. is $240.54 — it has increased by +0.56% in the past 24 hours. Watch Penumbra, Inc. stock price performance more closely on the chart.

  • Does Penumbra, Inc. release reports?

    Yes, you can track Penumbra, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Penumbra, Inc. stock forecast?

    Watch the Penumbra, Inc. chart and read a more detailed Penumbra, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Penumbra, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NYSE, exchange stock trades by Penumbra, Inc. stock ticker.

  • How to buy Penumbra, Inc. stocks?

    Like other stocks, PEN shares are sold on stock exchanges such as NYSE. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Penumbra, Inc.'s EBITDA?

    Penumbra, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Penumbra, Inc.’s financial statements.

  • What is the Penumbra, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0.0859254697, which equates to approximately 8.59%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Penumbra, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Penumbra, Inc.'s financials relevant news, and technical analysis. Penumbra, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Penumbra, Inc. stock currently indicates a “sell” signal. For more insights, review Penumbra, Inc.’s technical analysis.

  • A revenue figure for Penumbra, Inc. for its last quarter?

    Penumbra, Inc. published it's last quarterly revenues at $301.04 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.